Skip to main content
. 2022 Mar 3;8(1):3–14. doi: 10.1002/ibra.12026

Table 2.

CXCR4 and CXCL12 in AD

Reference IF Object Intervening measures Results
Thomas C. Beck et al. (2014) 10.892 B cells Interrupt the CXCR4 signal The export of immature B cells from BM is dependent on double downregulation of CXCR4
Yuval Gavriel et al. (2020) 3.517 AD Combined use of AMD3100 and l‐lactic acid in the treatment of AD The combined treatment resulted in a significant improvement in cognitive/memory functions and attenuated neuroinflammation
Simona Capsoni et al. (2017) 11.814 AD Mimic the parenchymal delivery of hNGFp used in clinical trials and intranasal injection of the same dose of hNGFp 2hNGFp acts on glial cells and regulates inflammatory proteins by regulating CXCL12

Note: Research on CXCR4 and CXCL12 over the recent years.

Abbreviations: AD, Alzheimer's disease; BM, bone marrow; CXCL12, CXC motif ligand 12; CXCR4, chemokine receptor type 4; hNGFp, human painless nerve growth factor.